Member Info for WeTookPelham

"07/10/2021
16:20 inanaco: hTTps://www.telegraph.co.uk/global-health/science-and-disease/taiwan-joins-race-develop-nasal-vaccine-trials-suggest-could/ Also this week, trials started in South Africa of a coronavirus vaccine delivered using a “needle-free” system. The vaccine, developed by scientists at the University of Nottingham and the immunotherapy company Scancell, targets a different part of the virus than the spike protein, which may mean it maintains its performance holds up better in the face of emerging variants when compared to the existing jabs. The needle free system, PharmaJet, uses a jet injector – a high-pressure, narrow stream of liquid fired through a nozzle to pierce the skin – to deliver the vaccine"

hTTps://www.telegraph.co.uk/global-health/science-and-disease/taiwan-joins-race-develop-nasal-vaccine-trials-suggest-could/

"...Taiwan joins race to develop nasal vaccine as trials suggest it could ...
1 hour ago — The vaccine, developed by scientists at the University of Nottingham and the immunotherapy company Scancell, targets a..."

https://pharmaceutical-journal.com/article/feature/never-again-training-our-immune-systems-to-neutralise-future-killer-coronaviruses

"....“Antibodies are such amazing molecules that are so sensitive and so selective, so they are really much more impacted by these kinds of mutational changes,” says Broderick. “Whereas T cells are less susceptible to a base pair change here and there.”

Similarly, biotech company Scancell has developed a DNA vaccine that targets the highly conserved nucleocapsid of the virus, in addition to the spike protein?[15]?."

Over on the other side, some great posts by marcusl2, definitely worth a read. He spotted this also:
HTTPS://www.mendeley.com/careers/job/research-associate-fellow-fixed-term-6552874

Also it seems Inanaco has been in touch with the Telegraph?

I would suggest that UK based company and two UK universities working together on a "universal" Covid vaccine and now has their first patient dosed (regardless of location) is news. But that's just my opinion.

@scousemark, I'm surprised Sky News haven't followed up with this story. Someone want to give Thomas Moore a nudge on Twitter?

2028 I believe, but article is saying big pharma like Merck need to plan years ahead with M&A, hence their recent huge acquisition.

https://www.ft.com/content/a9688ef3-42ad-4600-ac19-6b22783922c3

http://www.pharmatimes.com/news/first_subject_given_covid-19_vaccine_candidate_in_uk-based_scancells_covidity_trial_1379927 (n.b this link is not Https)

https://www.marketwatch.com/story/scancell-doses-first-subject-in-coronavirus-vaccine-trial-271633448357

But yes mainstream media exposure would be good too.

Exactly c11, perfectly put.
I'm just surprised I got the opportunity to top up this morning.

Purely IMO a good opportunity to top up.

Yep just to add to that question, what other potential RNS are you thinking C7?

Not sure time difference in Cape Town, an hour or two ahead? But maybe was announced very soon after dosing?
But also regarding timing of RNS, be very interesting to see any delayed trades tonight/tomorrow.
Tomorrow will be interesting in general I think.

Lol...great post RW.

Their ears must have been burning and had enough of all our moaning ;)

"Pfizer-BioNTech vaccine effectiveness wanes to 47% against infection after six months
Two doses of the vaccine are likely to keep those who contract the virus out of hospital six months later, but perform less well at preventing people from being infected with COVID-19."

https://news.sky.com/story/covid-19-pfizer-biontech-vaccine-effectiveness-wanes-to-47-against-infection-after-six-months-12426406

Explains the other Ugur Sahins other comment then.

https://www.cityam.com/new-covid-vaccine-formulation-could-be-needed-by-mid-2022-says-biontech-boss/

...at 22.40 for 155,000. Not delayed this time?

Thanks C7.

An interim/final results type RNS?
Also LSE RNS alerts seems to be down again?